Subsequent cancer in kidney cancer survivors:effect of family history

来源 :22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) | 被引量 : 0次 | 上传用户:bob01109
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: To elucidate the effect of family history on the development of subsequent cancer among kidney cancer survivors.Methods: We employed standardized incidence ratios (SIRs)to estimate the relative risk of subsequent cancer among kidney cancer survivors as well as survivors with family history by using the nationwide Swedish Family-Cancer Database (the worlds largest family-cancer database).A total of 32,132 patients diagnosed with first primary kidney cancer from 1958 to 2008were included.The patients family history of kidney and subsequent cancers was investigated.Interactions between the risk of second cancer and familial risk were tested by fitting the data to additive and multiplicative models.The familial risk of subsequent cancer was calculated for individuals with a family history of a specific cancer and compared with those without a family history of that cancer.
其他文献
Objective: To observe Wnt5aexpression of cells and tissues in breast cancer and non-cancerous tissue, and its relationship with the epithelial-mesenchymal transition (EMT).Methods: RT-PCR method was u
会议
Objective: Quality of Life (QOL) is the overall well-being of patients, which includes physical, emotional, mental, social,and behavioral components.The importance of this among cancer patients has be
会议
Objective: To explore the correlation between the protein expression and polymorphism of leptin receptor (LEPR) gene and the occurrence, development, and pathologic characteristics of breast cancer.Me
会议
Objective: To investigate whether or not MKK7 undergoes neddylation in breast cancer cells, including the possible biological significance of the finding.Methods: We chose the breast cancer cell lines
会议
Objective: To investigate the efficacy of vinorelbine plus cisplatin (NP regimen) in neoadjuvant chemotherapy of local advanced breast cancer with anthracycline and taxane resistance.Methods: One hund
会议
Objective: In the present study, we monitored the antiangiogenesis function of antagomir-21 (miR-21 inhibitor) in tumor angiogenesis in a VEGFR2-luc transgenic mouse model using bioluminescence imagin
会议
Objective: In clinical practice, breast cancers with lymph node metastasis, positive estrogen receptor/progesterone receptor,and overexpressed human epidermal growth factor receptor2 (LN+ER/PR-Her2+)
会议
Objective: In breast cancer, PARP inhibitors have been developed as single-agent in BRCA1/2-mutated tumors or in combination with chemotherapy.For optimization of PARP inhibitor treatment for cancer,
会议
Objective: To investigate the clinical, pathological, and prognostic characteristics of luminal B breast cancer patients with diabetes.Methods: In total, the study included 479 luminal B breast cancer
会议
Objective: To investigate a new adoptive immunotherapy method for renal cell carcinoma.Methods: Human umbilical cord blood (UCB) was obtained from volunteer mothers at the Affiliated Hospital of Guang
会议